Home»Latest 30days News on Medical, Biotech/Pharma - weSRCH
Click category or weSRCH domain below to read news from each weSRCH domain
High Tech:-Business, Consumer, Displays, IT, Mobile, Photo, Semiconductors
Medicine:-Biology, Biotech/Pharma, Equipment, Imaging, Implants, Practice Mngmnt, Therapy, Veterinary
Green Tech:-Battery & Fuel, Biomass, Environmental, Fossil/Nuclear, Lighting, Solar, Trans, Wind/Water/Geo
Business:-Companies, Entrepreneurial, IP/Law, Leadership & Strategy, Management, Sales & Marketing, Social Innovation

Latest News, Top News, Breaking News

    Total record(s) 1217 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>
    Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to ... - PharmiWeb.com (press release)
      It is first-generation TNF inhibitor consisting of a chimeric IgG1 mAb that is specific for TNFa. Remicade binds to TNFa with high affinity neutralizing the effects of this cytokine thus p ....more | Save |  Share  Email 26th Mar 2015 
    Purdue Extension offers Dining with Diabetes series - Kokomo Perspective
      Kokomo Perspective One out of every 11 people has diabetes. Another one in four doesn't know. Those are the figures that came out of the Centers for Disease Control and Prevention's 2014 study-and they're alarming to Li ....more | Save |  Share  Email 26th Mar 2015 
    Ancient Paleo-Lake Identified at Mars' Jezero Crater -- Could Reveal Biologic ... - The Daily Galaxy (blog)
      The Daily Galaxy (blog) "River and lake deposits on Earth are some of the best preservers of biologic signatures,? said Tim Goudge, a graduate student at Brown who led the work. " ....more | Save |  Share  Email 26th Mar 2015 
    Biotech Battering Renews Bubble Debate Over Sector's Pricey Stocks - Forbes
      Forbes Last summer, Federal Reserve Chair Janet Yellen said valuations in certain corners of the stock market like biotech were getting "substantially stretched,? and traders have gotten a good laugh at her warn ....more | Save |  Share  Email 26th Mar 2015 
    Trade-Ideas: Intercept Pharmaceuticals (ICPT) Is Today's "Barbarian At The ... - TheStreet.com
      TheStreet.com Trade-Ideas LLC identified Intercept Pharmaceuticals ( ICPT) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) can ....more | Save |  Share  Email 26th Mar 2015 
    ACADIA Pharmaceuticals At $30: The Upside Doesn't Justify The Risk - Seeking Alpha (registration)
      ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has been on a roller coaster ride recently, rising to over $45 on March 10 as the company missed two conferences that led to completely unfounded rumors of a b ....more | Save |  Share  Email 26th Mar 2015 
    Teesside CPI-led consortium handed £6.2m for new biologic treatments - Gazette Live
      A group led by Teesside-based Centre for Process Innovation (CPI) has secured a £6.2m Government cash boost to help UK firms develop new biologic treatments - creating 10 jobs in Darlington. The funds will help the UK ....more | Save |  Share  Email 26th Mar 2015 
    Synergy Pharma Said to Consider Sale Ahead of Trial Results - Bloomberg
      Motley Fool (Bloomberg) -- Synergy Pharmaceuticals Inc., a U.S. developer of drugs for gastrointestinal disorders, is talking to advisers about a potential sale of the company, according to people with knowledge of the ma ....more | Save |  Share  Email 26th Mar 2015 
    With diabetic nerve damage, walking can pose fall risk - Fox News
      Fox News Diabetics with nerve damage are more likely to have an uneven stride and struggle to maintain their balance even when walking on flat ground, a small study finds. So-called peripheral neuropathy, or diabetic nerve damage, can lea ....more | Save |  Share  Email 26th Mar 2015 
    Achillion Pharmaceuticals Becomes Oversold (ACHN) - Forbes
      Forbes In trading on Thursday, shares of Achillion Pharmaceuticals Inc. (NASD: ACHN) entered into oversold territory, hitting an RSI reading of 29.3, after changing hands as low as $9.7501 per share. By comparison, the current RSI reading of the ....more | Save |  Share  Email 26th Mar 2015 
    Trade negotiations should foster, encourage, promote biotech - The Hill (blog)
      As long-time business and scientific leaders, with around 40 years of experience each in biotechnology, we have seen firsthand how advances in science have transformed the medical standard of care for previously untreatable ....more | Save |  Share  Email 26th Mar 2015 
    May 8th Options Now Available For Isis Pharmaceuticals (ISIS) - Nasdaq
      Nasdaq Investors in Isis Pharmaceuticals, Inc. (Symbol: ISIS) saw new options begin trading today, for the May 8th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the ISIS options chain for the ne ....more | Save |  Share  Email 26th Mar 2015 
    What's Hot in Boston Biotech? Here's the Agenda - Xconomy
      Xconomy On April 8, we'll be hosting "What's Hot in Boston Biotech? at the Broad Institute of MIT and Harvard in Cambridge. We've put together a big lineup of executives, scientists, entrepreneurs, and investors across some ....more | Save |  Share  Email 26th Mar 2015 
    "It's a boom, not a bubble" -- except in biotech, Lindzon says - Yahoo Finance
      ETF Trends Overall, Lindzon believes "there is no bubble" in the broader market -- nor private markets for that matter -- but says the recent action in biotech is "very scary" and a sign of & ....more | Save |  Share  Email 26th Mar 2015 
    Aridis Pharmaceuticals Commences Phase 1 Clinical Study of Aerucin ... - PR Newswire (press release)
      News-Medical.net SAN JOSE, Calif., March 26, 2015 /PRNewswire/ -- Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel immunotherapies for infectio ....more | Save |  Share  Email 26th Mar 2015 
    Synergy Pharmaceuticals Said to Weigh Options Including Sale - Bloomberg
      Bloomberg (Bloomberg) -- Synergy Pharmaceuticals Inc., a U.S. developer of drugs for gastrointestinal disorders, is talking to advisers about options including a potential sale of the company, according to people with knowledge of ....more | Save |  Share  Email 26th Mar 2015 
    Inovio Pharmaceuticals (INO) Is Today's Dead Cat Bounce Stock - TheStreet.com
      TheStreet.com Trade-Ideas LLC identified Inovio Pharmaceuticals ( INO) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified I ....more | Save |  Share  Email 26th Mar 2015 
    Capsugel invests in vegetarian capsules citing demand for lower moisture ... - In-PharmaTechnologist.com
      The US capsule firm announced the investment today, describing it as enabling a combination of new production lines and technology upgrades at sites in Greenwood, South Carolina, U.S.; Puebla, Mexic ....more | Save |  Share  Email 26th Mar 2015 
    Biotech Crash -- How Long Will It Last? - Forbes
      The market croaked Wednesday as the very weak Durable Goods report gave investors more reasons to sell. The biotech and semiconductors bore the brunt of the selling as both were down over 4% on the day. The market internals were 3-1 negative but not  ....more | Save |  Share  Email 26th Mar 2015 
    PharmaPoint: Colorectal Cancer Research Report - Global Drug Forecast and ... - Digital Journal
      This class is likely to be led by Roches dual anti-VEGF/Ang2 inhibiting antibody vanucizumab (RO5520985; RG7221). Roche is currently investigating vanucizumab head-to-head against Avastin in a randomized Pha ....more | Save |  Share  Email 26th Mar 2015 
    Total record(s) 1217 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>